Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Angelo Cagnacci, Anjeza Xholli & Martina Venier. (2020) Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use. Patient Preference and Adherence 14, pages 55-62.
Read now
Read now
Rosaria Condorelli & Ines Vaz-Luis. (2018) Managing side effects in adjuvant endocrine therapy for breast cancer. Expert Review of Anticancer Therapy 18:11, pages 1101-1112.
Read now
Read now
G. P. Siliquini, V. Tuninetti, V. E. Bounous, F. Bert & N. Biglia. (2017) Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric 20:4, pages 379-384.
Read now
Read now
Santiago Palacios & María Jesús Cancelo. (2016) Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. International Journal of Women's Health 8, pages 617-626.
Read now
Read now
Rossella E. Nappi, Nicoletta Biglia, Angelo Cagnacci, Costantino Di Carlo, Stefano Luisi & Anna Maria Paoletti. (2016) Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group. Gynecological Endocrinology 32:8, pages 602-606.
Read now
Read now
A. J. Vincent. (2015) Management of menopause in women with breast cancer. Climacteric 18:5, pages 690-701.
Read now
Read now
P. Stute, T. W. May, C. Masur & I. M. Schmidts-Winkler. (2015) Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial. Climacteric 18:4, pages 582-589.
Read now
Read now
Diana D. Jeffery, Lisa Barbera, Barbara L. Andersen, Amy K. Siston, Anuja Jhingran, Shirley R. Baron, Jennifer Barsky Reese, Deborah J. Coady, Jeanne Carter & Kathryn E. Flynn. (2015) Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008–2014. Journal of Psychosocial Oncology 33:4, pages 433-466.
Read now
Read now
Luciano Mariani, Angiolo Gadducci, Enrico Vizza, Silverio Tomao & Patrizia Vici. (2013) Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy. Gynecological Endocrinology 29:1, pages 25-29.
Read now
Read now
Lian Ulrich. (2012) The role of local vaginal estrogen treatment in urogenital atrophy. Expert Review of Obstetrics & Gynecology 7:6, pages 545-556.
Read now
Read now
Cristina Tedeschi & Claudio Benvenuti. (2012) Comparison of vaginal gel isoflavones versus no topical treatment in vaginal dystrophy: results of a preliminary prospective study. Gynecological Endocrinology 28:8, pages 652-654.
Read now
Read now
. (2011) Relief of vaginal discomfort – hormones or water?. Climacteric 14:3, pages 398-399.
Read now
Read now
D. W. Sturdee & N. Panay. (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:6, pages 509-522.
Read now
Read now
Articles from other publishers (86)
Ana Carolina M. Comini, Bruno M. Carvalho, Matheus José Barbosa Moreira, Pedro C. Abrahão Reis, Luisa Colapietro, Jane Northern & Felipe Batalini. (2023) Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis. Clinical Breast Cancer 23:8, pages 835-846.
Crossref
Crossref
Elizabeth A. Casiano Evans, Deslyn T. G. Hobson, Sarit O. Aschkenazi, Alexandriah N. Alas, Sunil Balgobin, Ethan M. Balk, Alexis A. Dieter, Gregory Kanter, Francisco J. Orejuela, Tatiana V. D. Sanses & David D. Rahn. (2023) Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause. Obstetrics & Gynecology 142:3, pages 555-570.
Crossref
Crossref
Kristin Rojas, Laura M. Spring, Liz O’Riordan & Anna Weiss. (2023) Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects. Annals of Surgical Oncology.
Crossref
Crossref
Riccardo Vizza, Elisabetta Maria Capomolla, Livia Tosetto, Giacomo Corrado, Valentina Bruno, Benito Chiofalo, Francesca Sofia Di Lisa, Lorena Filomeno, Laura Pizzuti, Eriseld Krasniqi, Giuseppe Sanguineti, Alice Villa, Andrea Giannini, Ramy Kayal, Vincenzo Stranges, Silverio Tomao, Claudio Botti, Federica Tomao, Maddalena Barba, Enrico Vizza, Gennaro Ciliberto & Patrizia Vici. (2023) Sexual dysfunctions in breast cancer patients: evidence in context. Sexual Medicine Reviews 11:3, pages 179-195.
Crossref
Crossref
Matteo Lambertini, Luca Arecco, Terri Lynn Woodard, Audrey Messelt & Kristin E. Rojas. (2023) Advances in the Management of Menopausal Symptoms, Fertility Preservation, and Bone Health for Women With Breast Cancer on Endocrine Therapy. American Society of Clinical Oncology Educational Book:43.
Crossref
Crossref
Suneela Vegunta, Carol L. Kuhle, Jennifer A. Vencill, Pauline H. Lucas & Dawn M. Mussallem. (2022) Sexual Health after a Breast Cancer Diagnosis: Addressing a Forgotten Aspect of Survivorship. Journal of Clinical Medicine 11:22, pages 6723.
Crossref
Crossref
S. Vandamme, N. Willers & S. Han. (2022) Lokaal gebruik van dehydro-epiandrosteron voor de behandeling van vaginale atrofie na borstkanker. Tijdschrift voor Geneeskunde.
Crossref
Crossref
Fatemeh Sodeifian, Aida Mokhlesi & Farzad Allameh. (2022) Chemotherapy and Related Female Sexual Dysfunction: A Review of Literature. International Journal of Cancer Management 15:4.
Crossref
Crossref
Abbie J. Laing, Louise Newson & James A. Simon. (2022) Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development. The Cancer Journal 28:3, pages 196-203.
Crossref
Crossref
Ethan M. FanPhilippe E. Zimmern. (2022) Challenges of Managing Lower Urinary Tract Symptoms in Women with Tamoxifen Use. Women's Health Reports 3:1, pages 430-436.
Crossref
Crossref
Daniel María Lubián López. (2022) Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World Journal of Clinical Oncology 13:2, pages 71-100.
Crossref
Crossref
. (2021) Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer. Obstetrics & Gynecology 138:6, pages 950-960.
Crossref
Crossref
Sara Baldassari, Paola Cirrincione, Giorgia Ailuno, Giuliana Drava, Silvia Arpicco & Gabriele Caviglioli. (2021) Towards a better understanding of thermally treated polycarbophil matrix tablets for controlled release. International Journal of Pharmaceutics: X 3, pages 100098.
Crossref
Crossref
Shawna Johnston, Céline Bouchard, Michel Fortier & Wendy Wolfman. (2021) Directive clinique no 422b : Ménopause et santé génito-urinaire. Journal of Obstetrics and Gynaecology Canada 43:11, pages 1308-1315.e1.
Crossref
Crossref
Shawna Johnston, Céline Bouchard, Michel Fortier & Wendy Wolfman. (2021) Guideline No. 422b: Menopause and Genitourinary Health. Journal of Obstetrics and Gynaecology Canada 43:11, pages 1301-1307.e1.
Crossref
Crossref
Emory S. Buck, Vanessa A. Lukas & Rachel S. Rubin. (2021) Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause. Urology 151, pages 31-36.
Crossref
Crossref
C. Hocké, M. Diaz, V. Bernard, S. Frantz, M. Lambert, C. Mathieu & M. Grellety-Cherbero. (2021) Syndrome génito-urinaire de la ménopause (SGUM). RPC les femmes ménopausées du CNGOF et du GEMVi. Gynécologie Obstétrique Fertilité & Sénologie 49:5, pages 394-413.
Crossref
Crossref
Bohan Li, Hua Duan, Yanan Chang & Sha Wang. (2021) Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients. Pharmacological Research 164, pages 105360.
Crossref
Crossref
Tipatai Yodplob, Kun Sirisopana, Mutita Jongwannasiri, Pokket Sirisreetreerux, Wit Viseshsindh & Wachira Kochakarn. (2020) Local treatment with a polycarbophil-based cream in postmenopausal women with genitourinary syndrome of menopause. International Urogynecology Journal 32:2, pages 317-322.
Crossref
Crossref
Eduard Mension, Inmaculada Alonso & Camil Castelo-Branco. (2021) Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors – Systematic Review. Maturitas 143, pages 47-58.
Crossref
Crossref
E. V. Tikhomirova, V. E. Balan & O. S. Fomina-Nilova. (2020) Current treatment options for genitourinary syndrome. Meditsinskiy sovet = Medical Council:13, pages 91-96.
Crossref
Crossref
Angelica Lindén Hirschberg, Pedro Sánchez-Rovira, Jesús Presa-Lorite, Miriam Campos-Delgado, Miguel Gil-Gil, Elisabet Lidbrink, Javier Suárez-AlmarzaConcepción Nieto-Magro. (2020) Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial. Menopause 27:5, pages 526-534.
Crossref
Crossref
Laura M Chambers, Alyssa Herrmann, Chad M Michener, Cecile A Ferrando & Stephanie Ricci. (2020) Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma. International Journal of Gynecologic Cancer 30:4, pages 515-524.
Crossref
Crossref
Nicolás Mendoza, Rosalía Carrión, Loreto Mendoza-Huertas & Ana Rosa Jurado. (2020) Efficacy and Safety of Treatments to Improve Dyspareunia in Breast Cancer Survivors: A Systematic Review. Breast Care 15:6, pages 599-607.
Crossref
Crossref
Vanessa A. Lukas & James A. Simon. (2020) MsFLASH network vaginal health trial: absence of evidence is NOT evidence of absence. Menopause 27:6, pages 722-725.
Crossref
Crossref
Maurizio Filippini, Daniela Luvero, Stefano Salvatore, Annalisa PieralliRoberto Montera, Francesco Plotti, Massimo Candiani & Roberto Angioli. (2020) Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause 27:1, pages 43-49.
Crossref
Crossref
R.T. Pavlović, S.M. Janković, J.R. Milovanović, S.M. Stefanović, M.M. Folić, O.Z. Milovanović, C. Mamillapalli & M.N. Milosavljević. (2019) The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis. Clinical Breast Cancer 19:6, pages e731-e740.
Crossref
Crossref
Angelo Cagnacci, Mario Gallo, Marco Gambacciani & Stefano Lello. (2019) Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Società Italiana per la Menopausa (SIM) and the Società Italiana della Terza Età (SIGiTE). Minerva Ginecologica 71:5.
Crossref
Crossref
No Author. (2019) Chapitre 5 : Santé urogénitale. Journal of Obstetrics and Gynaecology Canada 41, pages S73-S81.
Crossref
Crossref
Fabiene Vale, Camilla Rezende, Alexon Raciclan, Tancredo Bretas & Selmo Geber. (2019) Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. European Journal of Obstetrics & Gynecology and Reproductive Biology 234, pages 92-95.
Crossref
Crossref
Sheryl A. Kingsberg, Lisa Larkin, Michael Krychman, Sharon J. Parish, Brian Bernick & Sebastian Mirkin. (2019) WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history. Menopause 26:2, pages 124-131.
Crossref
Crossref
Dimitrios Chatsiproios, Iris M. Schmidts-Winkler, Lisa König, Clarissa Masur & Christoph Abels. (2019) Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study. PLOS ONE 14:1, pages e0210967.
Crossref
Crossref
Marta D'Alonzo, Eleonora Piva, Silvia Pecchio, Viola Liberale, Paola Modaffari, Riccardo Ponzone & Nicoletta Biglia. (2018) Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers. Clinical Breast Cancer 18:6, pages e1361-e1366.
Crossref
Crossref
Caroline M. Mitchell, Susan D. Reed & Katherine A. Guthrie. (2018) Time to advocate for better science, and better treatments for women. Menopause 25:10, pages 1065-1068.
Crossref
Crossref
Susan J. Diem, Katherine A. Guthrie, Caroline M. Mitchell, Susan D. Reed, Joseph C. Larson, Kristine E. Ensrud & Andrea Z. LaCroix. (2018) Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause 25:10, pages 1086-1093.
Crossref
Crossref
Joan Pitkin. (2018) BMS – Consensus statement. Post Reproductive Health 24:3, pages 133-138.
Crossref
Crossref
Stephanie Wang Zuo, Harold WuWen Shen. (2018) Vaginal estrogen and mammogram results: case series and review of literature on treatment of genitourinary syndrome of menopause (GSM) in breast cancer survivors. Menopause 25:7, pages 828-836.
Crossref
Crossref
. (2018) Aromatase Inhibitors in Gynecologic Practice. Obstetrics & Gynecology 131:6, pages e194-e199.
Crossref
Crossref
Sophia Song, Aaron Budden, Asha Short, Erin Nesbitt‐Hawes, Rebecca Deans & Jason Abbott. (2017) The evidence for laser treatments to the vulvo‐vagina: Making sure we do not repeat past mistakes. Australian and New Zealand Journal of Obstetrics and Gynaecology 58:2, pages 148-162.
Crossref
Crossref
Ines Vaz-Luis & Ann H. Partridge. (2018) Exogenous reproductive hormone use in breast cancer survivors and previvors. Nature Reviews Clinical Oncology 15:4, pages 249-261.
Crossref
Crossref
Carly S. Sears, John W. Robinson & Lauren M. Walker. (2018) A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients. European Journal of Cancer Care 27:2, pages e12738.
Crossref
Crossref
Sharon L. Bober, Christopher J. Recklitis, Alexis L. Michaud & Alexi A. Wright. (2018) Improvement in sexual function after ovarian cancer: Effects of sexual therapy and rehabilitation after treatment for ovarian cancer. Cancer 124:1, pages 176-182.
Crossref
Crossref
Nicoletta Biglia, Valentina Elisabetta Bounous, Marta D'Alonzo, Laura Ottino, Valentina Tuninetti, Elisabetta Robba & Tania Perrone. (2017) Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists. Clinical Breast Cancer 17:8, pages 611-617.
Crossref
Crossref
Mehida Alexandre, Jonathan Black, Margaret Whicker, Mary Jane Minkin & Elena Ratner. (2017) The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in “previvors”. Maturitas 105, pages 46-51.
Crossref
Crossref
Mariana S. SousaMichelle Peate, Sherin Jarvis, Martha Hickey & Michael Friedlander. (2017) A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Therapeutic Advances in Medical Oncology 9:4, pages 269-285.
Crossref
Crossref
Meena Dayal & Preeti Yadav. (2017) Management of Postmenopausal Vaginal Atrophy: Review of Literature. Journal of SAFOMS 5:1, pages 51-57.
Crossref
Crossref
Jenifer Sassarini & Mary Ann Lumsden. 2017. Menopause. Menopause
249
260
.
Vanessa A. Lukas & James A. Simon. 2017. Essentials of Menopause Management. Essentials of Menopause Management
129
144
.
Rossella E. Nappi, Chiara Benedetto, Federica Campolo, Silvia Martella, Claudia Tosti, Antonio Cianci, Salvatore Caruso, Secondo Guaschino, Eva Grimaldi, Massimo Bagolan & Marco Sardina. (2016) Efficacy, tolerability and safety of a new medical device, Monurelle Biogel ® vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of reproductive age. European Journal of Obstetrics & Gynecology and Reproductive Biology 203, pages 82-88.
Crossref
Crossref
. (2016) Committee Opinion No. 663. Obstetrics & Gynecology 127:6, pages e170-e174.
Crossref
Crossref
. (2016) Committee Opinion No. 659. Obstetrics & Gynecology 127:3, pages e93-e96.
Crossref
Crossref
Susan M. Seav, Sally A. Dominick, Boris Stepanyuk, Jessica R. Gorman, Diana T. Chingos, Jennifer L. Ehren, Michael L. Krychman & H. Irene Su. (2015) Management of sexual dysfunction in breast cancer survivors: a systematic review. Women's Midlife Health 1:1.
Crossref
Crossref
Theodora Kunovac Kallak, Juliane Baumgart, Kerstin Nilsson, Helena Åkerud, Inger Sundström Poromaa & Anneli Stavreus-Evers. (2015) Vaginal Gene Expression During Treatment With Aromatase Inhibitors. Clinical Breast Cancer 15:6, pages 527-535.e2.
Crossref
Crossref
Nicoletta Biglia, Valentina E. Bounous, Luca G. Sgro, Marta D'Alonzo, Silvia Pecchio & Rossella E. Nappi. (2015) Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?. Clinical Breast Cancer 15:6, pages 413-420.
Crossref
Crossref
G. Donders, G. Bellen, P. Neven, P. Grob, V. Prasauskas, S. Buchholz & O. Ortmann. (2015) Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. European Journal of Clinical Microbiology & Infectious Diseases 34:10, pages 2023-2028.
Crossref
Crossref
Diane M. Parks & Jeffrey Levine. (2015) Helping Women Understand Treatment Options for Vulvar and Vaginal Atrophy. Nursing for Women's Health 19:4, pages 298-312.
Crossref
Crossref
Priscila Goncalves & Hunter Groninger. (2015) Sexual Dysfunction in Cancer Patients and Survivors #293. Journal of Palliative Medicine 18:8, pages 714-715.
Crossref
Crossref
J. Sassarini & M. A. Lumsden. (2015) Oestrogen replacement in postmenopausal women. Age and Ageing 44:4, pages 551-558.
Crossref
Crossref
Sallie Foley. (2015) Biopsychosocial Assessment and Treatment of Sexual Problems in Older Age. Current Sexual Health Reports 7:2, pages 80-88.
Crossref
Crossref
Andrea Bradford. (2014) Sexual Desire in Female Cancer Survivors. Current Sexual Health Reports 7:1, pages 30-37.
Crossref
Crossref
M. A. Weber, J. Limpens & J. P. W. R. Roovers. (2014) Assessment of vaginal atrophy: a review. International Urogynecology Journal 26:1, pages 15-28.
Crossref
Crossref
David D. Rahn, Cassandra Carberry, Tatiana V. Sanses, Mamta M. Mamik, Renée M. Ward, Kate V. Meriwether, Cedric K. Olivera, Husam Abed, Ethan M. Balk & Miles Murphy. (2014) Vaginal Estrogen for Genitourinary Syndrome of Menopause. Obstetrics & Gynecology 124:6, pages 1147-1156.
Crossref
Crossref
JoAnn E. Manson, Steven R. Goldstein, Risa Kagan, Andrew M. Kaunitz, James H. Liu, JoAnn V. Pinkerton, Robert W. Rebar, Peter F. Schnatz, Jan L. Shifren, Cynthia A. Stuenkel, Margery L.S. Gass & Wulf H. Utian. (2014) Why the product labeling for low-dose vaginal estrogen should be changed. Menopause 21:9, pages 911-916.
Crossref
Crossref
. (2014) RETIRED: Managing Menopause Chapter 5 Urogenital Health. Journal of Obstetrics and Gynaecology Canada 36:9, pages S35-S41.
Crossref
Crossref
David Sturdee. (2014) Urogenital atrophy. Post Reproductive Health 20:2, pages 73-75.
Crossref
Crossref
Gilbert Donders, Patrick Neven, Maximilian Moegele, Anneleen Lintermans, Gert Bellen, Valdas Prasauskas, Philipp Grob, Olaf Ortmann & Stefan Buchholz. (2014) Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Research and Treatment 145:2, pages 371-379.
Crossref
Crossref
Theodora Kunovac Kallak, Juliane Baumgart, Emma Göransson, Kerstin Nilsson, Inger Sundström Poromaa & Anneli Stavreus-Evers. (2014) Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors. Menopause 21:4, pages 383-390.
Crossref
Crossref
Susan WysockiSheryl KingsbergMichael Krychman. (2014) Management of Vaginal Atrophy: Implications from the REVIVE Survey. Clinical Medicine Insights: Reproductive Health 8, pages CMRH.S14498.
Crossref
Crossref
. (2013) Management of symptomatic vulvovaginal atrophy. Menopause 20:9, pages 888-902.
Crossref
Crossref
Rafael Sánchez-Borrego, Nicolás Mendoza, Estanislao Beltrán, Rafael Comino, Josep Allué, Camil Castelo-Branco, Maria Jesús Cornellana, Magda Duran, Javier Haya, Maria Dolores Juliá, Plácido Llaneza, Maria Concepción Navarro & Francisco Quereda. (2013) Position of the Spanish Menopause Society regarding the management of menopausal symptoms in breast cancer patients. Maturitas 75:3, pages 294-300.
Crossref
Crossref
Surveen Ghumman. (2013) Atrophic Vaginitis: Diagnosis and Treatment. Journal of SAFOMS 1:1, pages 4-12.
Crossref
Crossref
Juliane Baumgart, Kerstin Nilsson, Anneli Stavreus Evers, Theodora Kunovac Kallak & Inger Sundström Poromaa. (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 20:2, pages 162-168.
Crossref
Crossref
Vijayashree Murthy & Ronald S. Chamberlain. (2017) Menopausal Symptoms in Young Survivors of Breast Cancer: A Growing Problem without an Ideal Solution. Cancer Control 19:4, pages 317-329.
Crossref
Crossref
Santiago Palacios, M. Jesús Cancelo, Camil Castelo-Branco, Silvia González & Miguel Ángel Olalla. (2012) Recomendaciones de la Sociedad Española de Ginecología y Obstetricia sobre la prevención y el tratamiento de la atrofia vaginal. Progresos de Obstetricia y Ginecología 55:8, pages 408-415.
Crossref
Crossref
Margaret Rees, Faustino R. Pérez-López, Iuliana Ceasu, Herman Depypere, Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Yvonne T. van der Schouw & Florence Tremollieres. (2012) EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy. Maturitas 73:2, pages 171-174.
Crossref
Crossref
Isabelle Le Ray, Sophie Dell’Aniello, Franck Bonnetain, Laurent Azoulay & Samy Suissa. (2012) Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study. Breast Cancer Research and Treatment 135:2, pages 603-609.
Crossref
Crossref
Polly Niravath & Mothaffar Rimawi. (2012) Challenges in the treatment of younger women with breast cancer. Breast Cancer Management 1:2, pages 127-134.
Crossref
Crossref
Henrik Griesser, Stefan Skonietzki, Thomas Fischer, Karin Fielder & Marija Suesskind. (2012) Low dose estriol pessaries for the treatment of vaginal atrophy: A double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol. Maturitas 71:4, pages 360-368.
Crossref
Crossref
M. Moegele, S. Buchholz, S. Seitz, C. Lattrich & O. Ortmann. (2012) Vaginale Östrogentherapie bei MammakarzinompatientinnenVaginal estrogen therapy in breast cancer patients. Gynäkologische Endokrinologie 10:1, pages 57-60.
Crossref
Crossref
Sally Taylor, Clare Harley, Lucy Ziegler, Julia Brown & Galina Velikova. (2011) Interventions for sexual problems following treatment for breast cancer: a systematic review. Breast Cancer Research and Treatment 130:3, pages 711-724.
Crossref
Crossref
Jacky Owens & Leslie Walker. 2011. The Handbook of Contemporary Clinical Hypnosis. The Handbook of Contemporary Clinical Hypnosis
333
350
.
James A. Simon. (2011) Identifying and Treating Sexual Dysfunction in Postmenopausal Women: The Role of Estrogen. Journal of Women's Health 20:10, pages 1453-1465.
Crossref
Crossref
Jennifer Barsky Reese. (2011) Coping with sexual concerns after cancer. Current Opinion in Oncology 23:4, pages 313-321.
Crossref
Crossref
S. Loibl, A. Lintermans, A.S. Dieudonné & P. Neven. (2011) Management of menopausal symptoms in breast cancer patients. Maturitas 68:2, pages 148-154.
Crossref
Crossref
Sakina J. Rizvi, Niette W. Yeung & Sidney H. Kennedy. (2011) Instruments to measure sexual dysfunction in community and psychiatric populations. Journal of Psychosomatic Research 70:1, pages 99-109.
Crossref
Crossref
Libby Edwards. (2010) Dermatologic Causes of Vaginitis: A Clinical Review. Dermatologic Clinics 28:4, pages 727-735.
Crossref
Crossref